摘要:
A position adjustable outlet box system. The system has an outlet box cage, a mounting plate to which the outlet box cage is attached (having a outlet box aperture formed therein), an outlet box that is slideably retained in the outlet box cage, and a drywall ring having a projecting neck portion, which drywall ring is attachable to the outlet box. An adjustment mechanism is provided to permit adjustment of the depth position of the outlet box in the outlet box guide cage. The adjustment mechanism can includes a bolt that freely rotates along its axial axis (but does not move axially relative to the outlet box cage), a threaded shaft that screws into a threaded hole in a back wall of the outlet box and turning means that is accessible from within the outlet box to permit the outlet box's depth position within the cage to be adjusted as needed.
摘要:
A cover for pre-wired conduit boxes for use in installing sheet wall material around the conduit boxes, with or without mud rings having an opening and side walls, the conduit boxes having a front opening and spaced side walls and a back wall that define a cavity therein, and with fixtures and wiring contained therein. The cover is made from a puncture and ablation resistant material, such as steel, and has a face plate with a perimeter edge and apertures formed therethrough. The cover is sized to cover the front opening of the conduit box or the mud ring, and has arms extended rearwardly therefrom which are adapted to snugly engage with side walls of the conduit box of mud ring. The cover is preferable a unitary structure, and when the cover is placed over the front opening of the outlet box or mud ring, the perimeter of the cover provides a guide for a cutting tool, such as a router, which will allow a user to cut out an opening through the sheet material to complete installation of the wall sheet material. The cover is easily removable after the sheet wall material is installed and desired wall treatment (e.g. painting, wallpapering, etc.) is completed. The outlet boxes can be pre-wired with fixtures and wiring.
摘要:
Molten metal is injected uniformly into a horizontal mold from a feed chamber in a horizontal or vertical direction at a controlled rate, directly on top of the metal already within the mold. A cooling medium is applied to the bottom surface of the mold, with the type and flow rate of the cooling medium being varied to produce a controlled cooling rate throughout the casting process. The rate of introduction of molten metal and the flow rate of the cooling medium are both controlled to produce a relatively uniform solidification rate within the mold, thereby producing a uniform microstructure throughout the casting, and low stresses throughout the casting. A multiple layer ingot product is also provided comprising a base alloy layer and at least a first additional alloy layer, the two layers having different alloy compositions, where the first additional alloy layer is bonded directly to the base alloy layer by applying the first additional alloy in the molten state to the surface of the base alloy while the surface temperature of the base alloy is lower than the liquidus temperature and greater than eutectic temperature of the base alloy −50 degrees Celsuis.
摘要:
The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要:
Mutants of specific CC-chemokines containing a non-conservative substitution in a conserved consensus sequence act as CC-chemokine antagonists, and can be effectively used in the treatment of autoimmune and inflammatory diseases, cancers, and viral or bacterial infections. Particularly preferred are the RANTES/CCL5 mutants having the amino acid sequence of SEQ ID NO: 1, 2, 3, or 4.
摘要翻译:在保守的共有序列中含有非保守取代的特异性CC-趋化因子的突变体作为CC-趋化因子拮抗剂,可以有效地用于治疗自身免疫性和炎性疾病,癌症和病毒或细菌感染。 特别优选的是具有SEQ ID NO:1,2,3或4的氨基酸序列的RANTES / CCL5突变体。
摘要:
A structured scintillator and a detection system employing structured scintillators. More specifically, a structured scintillator comprising a scintillator material having a plurality of isolated structures is disclosed. The structures may be conical in shape. The structures may be formed on a substantially transparent material layer which has been patterned to form a plurality of isolated regions. The structures may be formed on top of the isolated regions to provide isolated scintillator structures having space therebetween. The isolated regions and scintillator structures may be aligned with underlying detection devices.
摘要:
The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
摘要:
Mutants of specific CC-chemokines containing a non-conservative substitution in a conserved consensus sequence act as CC-chemokine antagonists, and can be effectively used in the treatment of autoimmune and inflammatory diseases, cancers, and viral or bacterial infections. Particularly preferred are the RANTES/CCL5 mutants having the amino acid sequence of SEQ ID NO: 1, 2, 3, or 4.
摘要翻译:在保守的共有序列中含有非保守取代的特异性CC-趋化因子的突变体作为CC-趋化因子拮抗剂,可以有效地用于治疗自身免疫性和炎性疾病,癌症和病毒或细菌感染。 特别优选的是具有SEQ ID NO:1,2,3或4的氨基酸序列的RANTES / CCL5突变体。
摘要:
Variants of homodimer-forming chemokines, such as human CCL2, having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds and acting as an obligate monomer, can antagonize natural chemokines and have anti-inflammatory activity in vivo. These variants can be used as active ingredient in pharmaceutical compositions for the treatment of inflammatory, autoimmune, or infectious diseases.
摘要:
Novel antagonists of the chemokine CXCL8 (also known as Interleukin-8) can be obtained by generating mutants having specific combinations of non-conservative substitutions of basic amino acids located in the C-terminal region. Compounds prepared in accordance with the present invention can be used to block CXCL8 activity in vivo, thereby providing therapeutic compositions for use in the treatment or prevention of CXCL8-related diseases.